Namibija - angleščina - Namibia Medicines Regulatory Council

mirren (sa) (pty) ltd - caffeine; codeine phosphate; doxylamine succinate; paracetamol - tablet - each tablet contains paracetamol 450 mg, ; doxylamine succinate 5 mg, caffeine ; anhydrous 50 mg and codeine phosphate ; 10 m

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - doxylamine succinate, quantity: 5.1 mg; codeine phosphate hemihydrate, quantity: 10 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; purified talc; magnesium stearate; pregelatinised maize starch; sodium lauryl sulfate; colloidal anhydrous silica; hyprolose; stearic acid - for the temporary relief of acute moderate pain

Kenija - angleščina - Pharmacy and Poisons Board

eastleigh pharmaceuticals co. ltd eastleigh 2nd avenue, 14th street p.o box - paracetamol, codeine phosphate, doxylamine… - tablet - paracetamol bp 450 mg, codeine phosphate bp 10… - paracetamol combinations excl. psycholeptics

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - paracetamol; codeine phosphate; doxylamine succinate; caffeine - tablet - 450mg ; 10mg ; 5mg ; 30mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ssl international plc - paracetamol; codeine phosphate; doxylamine succinate; caffeine - tablet - 450mg ; 10mg ; 5mg ; 30mg

Irska - angleščina - HPRA (Health Products Regulatory Authority)

g & a licensing limited - paracetamol codeine phosphate hemihydrate doxylamine succinate caffeine - tablets - 450/10/5/3 milligram

Irska - angleščina - HPRA (Health Products Regulatory Authority)

seton products ltd - paracetamol codeine phosphate hemihydrate doxylamine succinate caffeine - tablets

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol; codeine phosphate; doxylamine succinate -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 450 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; magnesium stearate; purified talc; stearic acid; povidone; pregelatinised maize starch; crospovidone - indications as at 9 june 2020: mersyndol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 450 mg; codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose - mevadol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.